首页|RNA结合蛋白MEX3D和TSC22D1在宫颈癌组织中表达的相关性

RNA结合蛋白MEX3D和TSC22D1在宫颈癌组织中表达的相关性

扫码查看
探讨MEX3D蛋白和TSC22D1 mRNA在宫颈癌及癌旁组织中的表达并分析二者与宫颈癌患者临床表现的相关性。收集2020年6月至2023年6月在四川省妇幼保健院接受手术切除患者中获得的76份宫颈癌组织样本,以及匹配的癌旁正常组织样本。采用逆转录-荧光定量PCR方法(qRT-PCR)检测上述收集样本中TSC22D1 mRNA的表达水平,免疫组织化学法分析MEX3D蛋白在组织样本中的阳性表达,应用Spearman等级分析比较宫颈癌组织中TSC22D1蛋白和MEX3D mRNA表达与临床特征表现的相关性。TSC22D1 mRNA在宫颈癌组织中的表达量明显低于癌旁正常组织中相应的表达量(t=9。508,P<0。001),差异有统计学意义。与匹配的癌旁正常组织比较,76份宫颈癌组织样本中MEX3D蛋白的阳性表达明显上升(x2=64。083,P<0。05),差异具有统计学意义,且MEX3D蛋白是否表达与临床分期和淋巴结转移密切相关(x2=11。948,0。169;P均<0。05),而与年龄、浸润深度以及是否阴道浸润和宫旁浸润和肌层浸润无关。经Spearman相关性分析统计比较两者相关性,宫颈癌组织样本中TSC22D1 mRNA和MEX3D蛋白表达量呈现负相关性(r=-0。447,P<0。05)。RNA结合蛋白MEX3D在宫颈癌组织中相对匹配癌旁正常组织呈高表达,与TSC22D1 mRNA表达量呈负相关性,并且参与到宫颈癌的发生发展,两者在宫颈癌的诊疗过程中可作为新的治疗靶点和潜在的诊断方法。
Correlation between the Expression of RNA Binding Proteins MEX3D and TSC22D1 in Cervical Cancer Tissue
To investigate the expression of MEX3D protein and TSC22D1 mRNA in cervical cancer and adjacent tissues,and to ana-lyze the correlation between MEX3D protein and clinical manifestations of cervical cancer patients,a total of 76 cervical cancer tissue samples obtained from patients undergoing surgical resection in Sichuan Provincial Maternal and Child Health Hospital from June 2020 to June 2023,as well as matched adjacent normal tissue samples,were collected.Reverse transcription-fluorescence quantitative PCR(qRT-PCR)was used to detect the expression level of TSC22D1 mRNA in the collected samples,and the positive expression of MEX3D protein in tissue samples was analyzed by immunohistochemistry.Spearman grade analysis was used to compare the correla-tion between the expression of TSC22D1 protein and MEX3D mRNA and clinical features in cervical cancer tissues.The expression level of TSC22D1 mRNA in cervical cancer tissues was significantly lower than that in adjacent normal tissues,and the difference was statistically significant(t=9.508,P<0.001).Compared with the matched adjacent normal tissues,the positive expression of MEX3D protein in 76 cervical cancer tissue samples was significantly increased(x2=64.083,P<0.05),and the difference was statistically significant,and whether the expression of MEX3D protein was closely related to clinical stage and lymph node metastasis(x2=11.948,0.169;all P<0.05),but not with age,depth of invasion,vaginal invasion,parauterine invasion and myometrial inva-sion.Spearman correlation analysis showed that there was a negative correlation between the expression levels of TSC22D1 mRNA and MEX3D protein in cervical cancer tissue samples(r=-0.447,P<0.05).The RNA-binding protein MEX3D is highly expressed in cervical cancer tissues,which is negatively correlated with the expression of TSC22D1 mRNA,and is involved in the occurrence and development of cervical cancer,which can be used as new therapeutic targets and potential diagnostic methods in the diagnosis and treatment of cervical cancer.

MEX3DTSC22D1Cervical cancerClinical stagesLymph node metastasesMyometrial invasionPalazzo infiltration

余绍兰、关霞、单丽辉、聂大燕

展开 >

四川省妇幼保健院病理科,四川成都 610036

Mex-3家族成员D TSC22家庭成员D1 宫颈癌 临床分期 淋巴结转移 肌层浸润 宫旁浸润

四川省妇幼保健院院内科技创新基金项目

CXPJ2023-12

2024

药物生物技术
中国药科大学,中国医药科技出版社,中国药学会

药物生物技术

CSTPCD
影响因子:0.463
ISSN:1005-8915
年,卷(期):2024.31(4)